Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags

被引:29
作者
Driscoll, David F. [1 ,2 ,3 ]
Thoma, Andrea
Franke, Rolf
Klotsch, Karsten
Nehne, Jorg [4 ]
Bistrian, Bruce R.
机构
[1] Stable Solut LLC, Goleta, CA 93117 USA
[2] BIDMC, Nutr Infect Lab, Boston, MA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Hosp Care Pilot Plant Pharma, Melsungen, Germany
关键词
Additives; Control; quality; Electrolytes; Emulsions; Injections; Osmolarity; Particle size; Soybean oil; Stability; Storage; Triglycerides; Vehicles; Vitamins; INJECTABLE EMULSIONS; STABILITY; INFUSION; SAFETY; GLASS;
D O I
10.2146/ajhp080164
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The stability of injectable lipid emulsions in three-chamber plastic (3CP) bags, applying the globule-size limits established by United States Phormacopeia (USP) chapter 729, was studied. Methods. A total of five premixed total nutrient admixture (TNA) products packaged in 3CP bags from two different lipid manufacturers containing either 20% soybean oil or a mixture of soybean oil and medium-chain-triglyceride oil as injectable lipid emulsions were tested. Two low-osmolarity 3CP bags and three high-osmolarity 3CP bags were studied. All products were tested with the addition of trace elements and multivitamins. All additive conditions (with and without electrolytes) were tested in triplicate at time 0 (immediately after mixing) and at 6, 24, 30, and 48 hours after mixing; the bags were stored at 24-26 degrees C. All additives were equally distributed in each bag for comparative testing, applying both globule sizing methods outlined in USP chapter 729, Results. Of the bags tested, all bags from one manufacturer were coarse emulsions, showing signs of significant growth in the large-diameter tail when mixed as a TNA formulation and failing the limits set by method II of USP chapter 729 from the outset and throughout the study, while the bags from the other manufacturer were fine emulsions and met these limits. Of the bags that failed, significant instability was noted in one series containing additional electrolytes. Conclusion. Injectable lipid emulsions provided in 3CP bags that did not meet the globule-size limits of USP chapter 729 produced coarser TNA formulations than emulsions that met the USP limits.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 20 条
[11]  
Driscoll DF., 2004, PHARMACOPEIAL FORUM, V30, P2244
[12]   HEPATIC CYTOLYTIC AND CHOLESTATIC CHANGES RELATED TO A CHANGE OF LIPID EMULSIONS IN 4 LONG-TERM PARENTERAL-NUTRITION PATIENTS WITH SHORT BOWEL [J].
GERARDBONCOMPAIN, M ;
CLAUDEL, JP ;
GAUSSORGUES, P ;
SALORD, F ;
SIRODOT, M ;
CHEVALLIER, M ;
ROBERT, D .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1992, 16 (01) :78-83
[13]  
GUYTON AC, 1991, TXB MED PHYSL, P170
[14]   FAT EMULSION PARTICLE-SIZE - INFLUENCE ON THE CLEARANCE RATE AND THE TISSUE LIPOLYTIC-ACTIVITY [J].
LUTZ, O ;
MERAIHI, Z ;
MURA, JL ;
FREY, A ;
RIESS, GH ;
BACH, AC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 50 (06) :1370-1381
[15]   Incidence of Hypertriglyceridemia in critically ill neonates receiving lipid injectable emulsions in glass versus plastic containers: A retrospective analysis [J].
Martin, Camilia R. ;
Dumas, Gregory J. ;
Shoaie, Claire ;
Zheng, Zheng ;
Mackinnon, Brenda ;
Al-Aweel, Issa ;
Bistrian, Bruce R. ;
Pursley, Dewayne M. ;
Driscoll, David F. .
JOURNAL OF PEDIATRICS, 2008, 152 (02) :232-236
[16]  
Olivecrona G, 1998, Curr Opin Clin Nutr Metab Care, V1, P143, DOI 10.1097/00075197-199803000-00002
[17]   LIPID INTOLERANCE IN NEWBORNS IS ASSOCIATED WITH HEPATIC-DYSFUNCTION BUT NOT INFECTION [J].
TOCE, SS ;
KEENAN, WJ .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (11) :1249-1253
[18]  
*US PHARM, 2008, USP31NF26, P285
[19]  
*US PHARM CONV, 2008, US PHARM 31 REV NAT, P319
[20]  
*US PHARM CONV, 2008, US PHARM 31 REV NAT, P1927